论文信息 - SL-401, A Targeted Therapy Directed to the Interleukin-3 Receptor Present On Leukemia Blasts and Cancer Stem Cells, Is Active As a Single Agent in Patients with Advanced AML - 字舞流文

SL-401, A Targeted Therapy Directed to the Interleukin-3 Receptor Present On Leukemia Blasts and Cancer Stem Cells, Is Active As a Single Agent in Patients with Advanced AML

M. Konopleva | M. Andreeff | H. Kantarjian | G. Garcia-Manero | J. Cortes | T. Kadia | F. Ravandi | G. Borthakur | S. Kornblau | E. Rowinsky | A. Frankel | D. Rizzieri | M. Szarek | D. Hogge | C. Bivins | I. Bergstein | T. P. Cirrito | Kenneth Hoberman